ctla-4 ctla4 anti-ctla4 anti-ctla-4 cd152 anti-cd152 anti-cd-152 anti cd 152 ctla-4/cd152 ctla4/cd152 antibody immunohistochemistry ihc

CTLA-4 Antibody Immunohistohemistry on an FFPE Tonsil Tissue

United States
Research Use
Safety Data Sheet
Control Slides
Intended UseFor Analyte Specific Reagent
Summary and Explanation

CTLA-4 antibody or CTLA4 (cytotoxic T-lymphocyte-associated protein 4), classified as CD152, is a protein receptor known to functions as an immune checkpoint which downregulates the immune system. CTLA4 is found on the surface of T cells, and acts as an “off” switch when bound to CD80 or CD86 on the surface of antigen-presenting cells. The CTLA-4 protein is encoded by the Ctla4 gene in mice and the CTLA4 gene in humans. CTLA-4 is a member of the immunoglobulin superfamily that is expressed on the surface of Helper T cells and transmits an inhibitory signal to T cells. CTLA-4 is similar to the T-cell co-stimulatory protein, CD28, and both molecules bind to CD80 and CD86, also called B7-1 and B7-2 respectively, on antigen-presenting cells. CTLA-4 transmits an inhibitory signal to T cells, whereas CD28 transmits a stimulatory signal. Intracellular CTLA4 is also found in regulatory T cells and may be important to their function. T cell activation through the T cell receptor and CD28 leads to increased expression of CTLA-4, an inhibitory receptor for B7 molecules.

Mutations in this gene have been associated with insulin-dependent diabetes mellitus, Graves’ disease, Hashimoto’s thyroiditis, celiac disease, systemic lupus erythematosus, thyroid-associated orbitopathy, primary biliary cirrhosis and other autoimmune diseases.  Polymorphisms of the CTLA-4 gene are associated with autoimmune diseases such as autoimmune thyroid disease and multiple sclerosis, though this association is often weak. In Systemic Lupus Erythematosus (SLE), the splice variant sCTLA-4 is found to be aberrantly produced and found in the serum of patients with active SLE. Germline haploinsufficiency of CTLA4 leads to CTLA4 deficiency or CHAI disease (CTLA4 haploinsufficiency with autoimmune infiltration), a rare genetic disorder of the immune system. This may cause a dysregulation of the immune system and may result in lymphoproliferation, autoimmunity, hypogammaglobulinemia, recurrent infections, and may slightly increase one’s risk of lymphoma.

Antibody TypeMouse MonoclonalCloneBSB-88
IsotypeIgG2a/KReactivityParaffin, Frozen
LocalizationMembranousControlTonsil, Lymph Node, Colon, Thymus
PresentationCTLA-4 / CD152 is a mouse monoclonal antibody derived from cell culture supernatant that is concentrated, dialyzed, filter sterilized and diluted in buffer pH 7.5, containing BSA and sodium azide as a preservative.
Catalog No.Antibody TypeDilutionVolume/QTY
BSB 2880PredilutedReady-To-Use3.0 ml
BSB 2881PredilutedReady-To-Use7.0 ml
BSB 2882PredilutedReady-To-Use15.0 ml
BSB 2883Concentrated1:25-1:1000.1 ml
BSB 2884Concentrated1:25-1:1000.5 ml
BSB 2885Concentrated1:25-1:1001.0 ml
BSB 2886Control Slides5
Note: For concentrated antibodies, please centrifuge prior to use to ensure recovery of all product.
Synonyms: CD152, CTLA 4, CTLA4, anti-CTLA-4, anti CTLA-4, anti-CTLA 4, anti-CTLA4, anti CTLA 4, anti CTLA4, anti-CD152, anti CD152, CD, CD152 isoform, celiac disease 3, CELIAC3, cytotoxic T lymphocyte associated antigen 4 short spliced form, cytotoxic T lymphocyte antigen 4, Cytotoxic T lymphocyte protein 4, Cytotoxic T lymphocyte associated antigen 4, cytotoxic T lymphocyte associated protein 4, cytotoxic T lymphocyte associated serine esterase 4, GRD4, GSE, ICOS, IDDM12, ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4